BRISTOL-MYERS SQUIBB CO (1BMY.MI) Stock Fundamental Analysis
Europe - BIT:1BMY - US1101221083 - Common Stock
38.4 EUR
-1.26 (-3.18%)
1BMY gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 54 industry peers in the Pharmaceuticals industry. Both the profitability and the financial health of 1BMY get a neutral evaluation. Nothing too spectacular is happening here. 1BMY scores decently on growth, while it is valued quite cheap. This could make an interesting combination. 1BMY also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year 1BMY was profitable.
1BMY had a positive operating cash flow in the past year.
In multiple years 1BMY reported negative net income over the last 5 years.
Each year in the past 5 years 1BMY had a positive operating cash flow.
1.2 Ratios
The Return On Assets of 1BMY (5.33%) is comparable to the rest of the industry.
With a decent Return On Equity value of 28.96%, 1BMY is doing good in the industry, outperforming 77.78% of the companies in the same industry.
With a decent Return On Invested Capital value of 16.07%, 1BMY is doing good in the industry, outperforming 79.63% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1BMY is below the industry average of 14.87%.
The last Return On Invested Capital (16.07%) for 1BMY is above the 3 year average (11.67%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.33% | ||
| ROE | 28.96% | ||
| ROIC | 16.07% |
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)11.67%
ROIC(5y)9.83%
1.3 Margins
1BMY has a Profit Margin of 10.58%. This is comparable to the rest of the industry: 1BMY outperforms 46.30% of its industry peers.
With a decent Operating Margin value of 30.27%, 1BMY is doing good in the industry, outperforming 77.78% of the companies in the same industry.
1BMY's Operating Margin has declined in the last couple of years.
1BMY has a Gross Margin of 73.92%. This is in the better half of the industry: 1BMY outperforms 62.96% of its industry peers.
1BMY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 30.27% | ||
| PM (TTM) | 10.58% | ||
| GM | 73.92% |
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
2. Health
2.1 Basic Checks
1BMY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for 1BMY has been reduced compared to 1 year ago.
Compared to 5 years ago, 1BMY has less shares outstanding
The debt/assets ratio for 1BMY is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.03 indicates that 1BMY is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of 1BMY (2.03) is worse than 62.96% of its industry peers.
1BMY has a debt to FCF ratio of 3.37. This is a good value and a sign of high solvency as 1BMY would need 3.37 years to pay back of all of its debts.
1BMY has a Debt to FCF ratio of 3.37. This is comparable to the rest of the industry: 1BMY outperforms 59.26% of its industry peers.
A Debt/Equity ratio of 2.56 is on the high side and indicates that 1BMY has dependencies on debt financing.
1BMY's Debt to Equity ratio of 2.56 is on the low side compared to the rest of the industry. 1BMY is outperformed by 79.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.56 | ||
| Debt/FCF | 3.37 | ||
| Altman-Z | 2.03 |
ROIC/WACC2.06
WACC7.8%
2.3 Liquidity
A Current Ratio of 1.21 indicates that 1BMY should not have too much problems paying its short term obligations.
1BMY has a Current ratio (1.21) which is comparable to the rest of the industry.
1BMY has a Quick Ratio of 1.11. This is a normal value and indicates that 1BMY is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of 1BMY (1.11) is better than 74.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.11 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 391.24% over the past year.
The earnings per share for 1BMY have been decreasing by -24.57% on average. This is quite bad
Looking at the last year, 1BMY shows a small growth in Revenue. The Revenue has grown by 2.57% in the last year.
1BMY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.06% yearly.
EPS 1Y (TTM)391.24%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-29.47%
Revenue 1Y (TTM)2.57%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%0.56%
3.2 Future
1BMY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.11% yearly.
Based on estimates for the next years, 1BMY will show a decrease in Revenue. The Revenue will decrease by -4.99% on average per year.
EPS Next Y477.64%
EPS Next 2Y131.04%
EPS Next 3Y73.61%
EPS Next 5Y36.11%
Revenue Next Year-1.12%
Revenue Next 2Y-4.71%
Revenue Next 3Y-3.48%
Revenue Next 5Y-4.99%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 6.67 indicates a rather cheap valuation of 1BMY.
Compared to the rest of the industry, the Price/Earnings ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 92.59% of the companies listed in the same industry.
1BMY's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.91.
With a Price/Forward Earnings ratio of 7.37, the valuation of 1BMY can be described as very cheap.
1BMY's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1BMY is cheaper than 90.74% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.57. 1BMY is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.67 | ||
| Fwd PE | 7.37 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 88.89% of the companies listed in the same industry.
1BMY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1BMY is cheaper than 94.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.26 | ||
| EV/EBITDA | 6 |
4.3 Compensation for Growth
1BMY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as 1BMY's earnings are expected to grow with 73.61% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y131.04%
EPS Next 3Y73.61%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 5.72%, 1BMY is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.89, 1BMY pays a better dividend. On top of this 1BMY pays more dividend than 92.59% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, 1BMY pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.72% |
5.2 History
On average, the dividend of 1BMY grows each year by 11.67%, which is quite nice.
Dividend Growth(5Y)11.67%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
98.12% of the earnings are spent on dividend by 1BMY. This is not a sustainable payout ratio.
1BMY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP98.12%
EPS Next 2Y131.04%
EPS Next 3Y73.61%
BIT:1BMY (10/7/2025, 7:00:00 PM)
38.4
-1.26 (-3.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners82.84%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap78.16B
Revenue(TTM)47.70B
Net Income(TTM)5.05B
Analysts67.27
Price Target44.38 (15.57%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.72% |
Yearly Dividend2.07
Dividend Growth(5Y)11.67%
DP98.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.2%
Min EPS beat(2)19.36%
Max EPS beat(2)35.04%
EPS beat(4)4
Avg EPS beat(4)21.86%
Min EPS beat(4)13.54%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)17.22%
EPS beat(12)11
Avg EPS beat(12)11.73%
EPS beat(16)15
Avg EPS beat(16)9.9%
Revenue beat(2)2
Avg Revenue beat(2)5.24%
Min Revenue beat(2)3.68%
Max Revenue beat(2)6.79%
Revenue beat(4)4
Avg Revenue beat(4)5.13%
Min Revenue beat(4)3.68%
Max Revenue beat(4)6.79%
Revenue beat(8)7
Avg Revenue beat(8)3.53%
Revenue beat(12)8
Avg Revenue beat(12)1.72%
Revenue beat(16)10
Avg Revenue beat(16)1.44%
PT rev (1m)-3.96%
PT rev (3m)-9.57%
EPS NQ rev (1m)-5.08%
EPS NQ rev (3m)-7.02%
EPS NY rev (1m)0.08%
EPS NY rev (3m)-5.25%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)1.21%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)2.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.67 | ||
| Fwd PE | 7.37 | ||
| P/S | 1.91 | ||
| P/FCF | 6.26 | ||
| P/OCF | 5.74 | ||
| P/B | 5.24 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6 |
EPS(TTM)5.76
EY15%
EPS(NY)5.21
Fwd EY13.57%
FCF(TTM)6.13
FCFY15.97%
OCF(TTM)6.69
OCFY17.42%
SpS20.06
BVpS7.33
TBVpS-10.82
PEG (NY)0.01
PEG (5Y)N/A
Graham Number30.83
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.33% | ||
| ROE | 28.96% | ||
| ROCE | 21.51% | ||
| ROIC | 16.07% | ||
| ROICexc | 20.14% | ||
| ROICexgc | 101.89% | ||
| OM | 30.27% | ||
| PM (TTM) | 10.58% | ||
| GM | 73.92% | ||
| FCFM | 30.56% |
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)11.67%
ROIC(5y)9.83%
ROICexc(3y)13.73%
ROICexc(5y)11.71%
ROICexgc(3y)74.95%
ROICexgc(5y)76.74%
ROCE(3y)15.62%
ROCE(5y)13.15%
ROICexgc growth 3Y-16.88%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y7.41%
ROICexc growth 5Y19.82%
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.56 | ||
| Debt/FCF | 3.37 | ||
| Debt/EBITDA | 2.14 | ||
| Cap/Depr | 20.37% | ||
| Cap/Sales | 2.77% | ||
| Interest Coverage | 6.99 | ||
| Cash Conversion | 75.95% | ||
| Profit Quality | 288.73% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.11 | ||
| Altman-Z | 2.03 |
F-Score7
WACC7.8%
ROIC/WACC2.06
Cap/Depr(3y)12.09%
Cap/Depr(5y)10.53%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)391.24%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-29.47%
EPS Next Y477.64%
EPS Next 2Y131.04%
EPS Next 3Y73.61%
EPS Next 5Y36.11%
Revenue 1Y (TTM)2.57%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%0.56%
Revenue Next Year-1.12%
Revenue Next 2Y-4.71%
Revenue Next 3Y-3.48%
Revenue Next 5Y-4.99%
EBIT growth 1Y30.41%
EBIT growth 3Y0.79%
EBIT growth 5Y8.21%
EBIT Next Year263.82%
EBIT Next 3Y49.42%
EBIT Next 5Y23.71%
FCF growth 1Y35.99%
FCF growth 3Y-2.91%
FCF growth 5Y14.03%
OCF growth 1Y34.19%
OCF growth 3Y-2.14%
OCF growth 5Y13.49%
BRISTOL-MYERS SQUIBB CO / 1BMY.MI FAQ
Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a fundamental rating of 5 / 10 to 1BMY.MI.
What is the valuation status of BRISTOL-MYERS SQUIBB CO (1BMY.MI) stock?
ChartMill assigns a valuation rating of 9 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.
Can you provide the profitability details for BRISTOL-MYERS SQUIBB CO?
BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 5 / 10.
What is the financial health of BRISTOL-MYERS SQUIBB CO (1BMY.MI) stock?
The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 4 / 10.
How sustainable is the dividend of BRISTOL-MYERS SQUIBB CO (1BMY.MI) stock?
The dividend rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 7 / 10 and the dividend payout ratio is 98.12%.